Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Logo for

J. Pharmacol. Exp. Ther. 318 (2): 563-570

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.

BEHAVIORAL PHARMACOLOGY

Pharmacological Characterization of Hydrolysis-Resistant Analogs of Oleoylethanolamide with Potent Anorexiant Properties

Giuseppe Astarita, Barbara Di Giacomo, Silvana Gaetani1, Fariba Oveisi, Timothy R. Compton, Silvia Rivara, Giorgio Tarzia, Marco Mor, and Daniele Piomelli

Department of Pharmacology, University of California, Irvine, California (G.A., S.G., F.O., D.P.); Kadmus Pharmaceuticals, Inc., Irvine, California (T.R.C.); Institute of Medicinal Chemistry, University of Urbino, Urbino, Italy (B.D.G., G.T.); Dipartimento Farmaceutico, University of Parma, Parma, Italy (M.M., S.R.); and Center for Drug Discovery, University of California, Irvine, California (G.A., D.P.)

Abstract: Oleoylethanolamide (OEA) is an endogenous lipid mediator that reduces food intake, promotes lipolysis, and decreases body weight gain in rodents by activating peroxisome proliferator-activated receptor-{alpha} (PPAR-{alpha}). The biological effects of OEA are terminated by two intracellular lipid hydrolase enzymes, fatty-acid amide hydrolase and N-acylethanolamine-hydrolyzing acid amidase. In the present study, we describe OEA analogs that resist enzymatic hydrolysis, activate PPAR-{alpha} with high potency in vitro, and persistently reduce feeding when administered in vivo either parenterally or orally. The most potent of these compounds, (Z)-(R)-9-octadecenamide,N-(2-hydroxyethyl,1-methyl) (KDS-5104), stimulates transcriptional activity of PPAR-{alpha} with a half-maximal effective concentration (EC50) of 100 ± 21 nM (n = 11). Parenteral administration of KDS-5104 in rats produces persistent dose-dependent prolongation of feeding latency and postmeal interval (half-maximal effective dose, ED50 = 2.4 ± 1.8 mg kg-1 i.p.; n = 18), as well as increased and protracted tissue exposure compared with OEA. Oral administration of the compound also results in a significant tissue exposure and reduction of food intake in free-feeding rats. These results suggest that the endogenous high-affinity PPAR-{alpha} agonist OEA may provide a scaffold for the discovery of novel orally active PPAR-{alpha} ligands.


Received for publication March 24, 2006. Accepted for publication May 12, 2006.

Address correspondence to: Dr. Daniele Piomelli, Department of Pharmacology, 360 MSRII, University of California, Irvine, CA 92697-4625. E-mail: piomelli{at}uci.edu

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
AM404 attenuates reinstatement of nicotine seeking induced by nicotine-associated cues and nicotine priming but does not affect nicotine- and food-taking.
I. Gamaleddin, M. Guranda, M. Scherma, W. Fratta, A. Makriyannis, S. K. Vadivel, S. R. Goldberg, and B. Le Foll (2013)
J Psychopharmacol 27, 564-571
   Abstract »    Full Text »    PDF »
Effects of palmitoylethanolamide on intestinal injury and inflammation caused by ischemia-reperfusion in mice.
R. Di Paola, D. Impellizzeri, A. Torre, E. Mazzon, A. Cappellani, C. Faggio, E. Esposito, F. Trischitta, and S. Cuzzocrea (2012)
J. Leukoc. Biol. 91, 911-920
   Abstract »    Full Text »    PDF »
Decreased body weight and hepatic steatosis with altered fatty acid ethanolamide metabolism in aged L-Fabp -/- mice.
E. P. Newberry, S. M. Kennedy, Y. Xie, J. Luo, R. M. Crooke, M. J. Graham, J. Fu, D. Piomelli, and N. O. Davidson (2012)
J. Lipid Res. 53, 744-754
   Abstract »    Full Text »    PDF »
Lipid transport function is the main target of oral oleoylethanolamide to reduce adiposity in high-fat-fed mice.
C. Thabuis, F. Destaillats, D. M. Lambert, G. G. Muccioli, M. Maillot, T. Harach, D. Tissot-Favre, and J.-C. Martin (2011)
J. Lipid Res. 52, 1373-1382
   Abstract »    Full Text »    PDF »
Fat-induced satiety factor oleoylethanolamide enhances memory consolidation.
P. Campolongo, B. Roozendaal, V. Trezza, V. Cuomo, G. Astarita, J. Fu, J. L. McGaugh, and D. Piomelli (2009)
PNAS 106, 8027-8031
   Abstract »    Full Text »    PDF »
GPR119 Is Essential for Oleoylethanolamide-Induced Glucagon-Like Peptide-1 Secretion From the Intestinal Enteroendocrine L-Cell.
L. M. Lauffer, R. Iakoubov, and P. L. Brubaker (2009)
Diabetes 58, 1058-1066
   Abstract »    Full Text »    PDF »
Inhibition of Anandamide Hydrolysis by Cyclohexyl Carbamic Acid 3'-Carbamoyl-3-yl Ester (URB597) Reverses Abuse-Related Behavioral and Neurochemical Effects of Nicotine in Rats.
M. Scherma, L. V. Panlilio, P. Fadda, L. Fattore, I. Gamaleddin, B. Le Foll, Z. Justinova, E. Mikics, J. Haller, J. Medalie, et al. (2008)
J. Pharmacol. Exp. Ther. 327, 482-490
   Abstract »    Full Text »    PDF »
Effects of Palmitoylethanolamide on Signaling Pathways Implicated in the Development of Spinal Cord Injury.
T. Genovese, E. Esposito, E. Mazzon, R. D. Paola, R. Meli, P. Bramanti, D. Piomelli, A. Calignano, and S. Cuzzocrea (2008)
J. Pharmacol. Exp. Ther. 326, 12-23
   Abstract »    Full Text »    PDF »
Targeted enhancement of oleoylethanolamide production in proximal small intestine induces across-meal satiety in rats.
J. Fu, J. Kim, F. Oveisi, G. Astarita, and D. Piomelli (2008)
Am J Physiol Regulatory Integrative Comp Physiol 295, R45-R50
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882